23 September 2025
Obituary—Prof. Dr. Anahid Jewett
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
It is with profound sadness that we share the news that Prof. Dr. Anahid Jewett, esteemed Section Board Member of Cells and Professor in the Division of Oral Biology and Medicine at the University of California, Los Angeles (UCLA), passed away in 2025.
Prof. Dr. Jewett was an internationally recognized immunologist whose pioneering research profoundly advanced our understanding of the immune system’s role in cancer, with a particular focus on natural killer (NK) cells. Her work illuminated the mechanisms by which NK cells regulate tumor progression and immune surveillance, paving the way for novel therapeutic approaches in cancer immunotherapy.
Throughout her distinguished career at UCLA and the Jonsson Comprehensive Cancer Center, Prof. Dr. Jewett was dedicated to both scientific innovation and mentorship. She authored numerous influential publications that shaped the field of tumor immunology and was widely respected for her contributions to translational research bridging basic science and clinical application.
As a Section Board Member of Cells, Prof. Dr. Jewett played a vital role in supporting the journal’s mission to foster high-quality research dissemination. Her insight, dedication, and generosity enriched the scientific community and inspired colleagues and students alike.
We extend our heartfelt condolences to Prof. Dr. Jewett’s family, friends, and colleagues. Her legacy as a scientist, mentor, and leader will endure in the field of cancer immunology and beyond.
Cells Editorial Office